The premenstrual syndrome: Effectiveness of Vitex agnus castus;Das prämenstruelle Syndrom Wirksamkeit von Vitex agnus castus

Medizinische Monatsschrift fur Pharmazeuten

Volumn 32, Issue 5, 2009, Pages 186-191

  Döll, Michaela ^a   Wachenheim, ^a  

^a Gartenweg 20 ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; VITEX AGNUS CASTUS EXTRACT;

ANXIETY; BREAST TENDERNESS; CLINICAL TRIAL; DEPRESSION; DIET; EMOTIONAL STRESS; HUMAN; HYPERPROLACTINEMIA; LIFESTYLE; MOOD CHANGE; PREMENSTRUAL SYNDROME; PROLACTIN BLOOD LEVEL; REVIEW; ADULT; CHEMISTRY; FEMALE; PATHOLOGY; PHYTOTHERAPY; VITEX;

ADULT; FEMALE; HUMANS; HYPERPROLACTINEMIA; PHYTOTHERAPY; PREMENSTRUAL SYNDROME; VITEX; YOUNG ADULT;

EID: 67049167224     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Massil H, O'Brien PM. Premenstrual syndrome. Br Med J (Clin Res Ed) 1986;293:1289-92.
2. Meyl Ch. Therapie des prämenstruellen Syndroms. Therapeutikon 1991;5:518-25.
3. Zahradnik HP. Prämenstruelles Syndrom. Gynäkol Endokrin 2004;2:64-9.
4. Küpper C, Loch EG. Prämenstruelles Syndrom. Dtsch Apoth Ztg 1996;136:1987-93.
5. Freeman EW, Schweizer E, Rickets K. Personality factors in women with premenstrual syndrome. Psychosom Med 1995;57:453-9.
6. ACOG (American College of Obstreticians and Gynecologists). Pre-mestrual Syndrome. ACOG Practice Bull 2000;15:1-9.
7. APA (American Psychiatric Association). Diagnostic and Statistical Manual of Mental Disorders. 4th edition. (DSMIV). Washington D.C.: American Psychiatric Associaton, 1994:715-8.
8. Kendler KS, et al. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol Med 1992;22:85-100.
9. Masho SW, et al. Obesity as a risk factor for premenstrual syndrome. J Psychosom Obstet Gynaecol 2005;26:33-9.
10. Parry BL, et al. Blunted phase shift responses to morning bright light in premenstrual dysphoric disorder. J Biol Rhythms 1997;12:443-56.
11. Rapkin A, et al. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinolog 2003;28:39-53.
12. Wuttke W, etal. Behandlung zyklusabhängiger Brustschmerzen mit einem Agnus castus-haltigen Arzneimittel. Geburtshilfe und Frauenheil-kunde 1997;57:4-14.
13. Schulz BCD, etal. Der Einfluss Prolaktininhibierender Substanzen auf den normalen Zyklus und auf Prolaktin-abhängige, normoprolaktin-ämische Erkrankungen der Frau. Gynäkol 1977; 10:113-20.
14. Ziegert M, et al. Hyperprolaktinämie. Gynäkol 2001;43:161-72.
15. Parry BL, etal. Mood disorders and the reproductive cycle. Gender-Specific Med 2000;3:53-8.
16. Huber J. Endokrine Gynäkologie. Einführung in die frauenspezifísche Medizin. Wien, München, Bern: Verlag W. Maudrich, 1998.
17. Schneider HP, etal. Prolactin and the inadequate corpus luteum. In: Calve D, Horowski R, McDonalds R, Wuttke W (eds.). Lisuride and other dopamine agonists. New York: Raven Press, 1983:313-23.
18. Abel G, et al. In: Hager H, Hänsel R, Keller K, Rimpler H (eds.). Ha-gers Handbuch der pharmazeutischen Praxis. 5. Auflage, Band 6. Berlin, Heidelberg, New York: Springer-Verlag, 1994.
19. Meier B, et al. Agni-casti fructus. Z Phytotherapie 1999;20:140-58.
20. Ono M, et al. Five new diterpenoids, viteagnusins A-E from the fruit of vitex agnus-castus. Chem Pharm Bull 2008;56:1621-4.
21. Jarry H, et al. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994;102:446-54.
22. Wuttke W, et al. Chaste tree (Vitex agnus-castus) - Pharmacology and clinical indications. Phytomed 2003;10:348-57.
23. Wuttke W, et al. Extrakte aus Mönchspfeffer (Vitex Agnus castus). Gynäkol Endokrinol 2008;2:82-6.
24. Besser GM, et al. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations. Br J Pharmacol 1980;71:569-73.
25. Ôksa S, et al. Toremifen for premenstrual mastalgia: A randomised, placebo-controlled cross-over study. BJOG 2006;113:713-8.
26. Gong C, et al. A double-blind randomized controlled trial of toremifen therapy for mastalgia. Arch Surg 2006; 1411:43-7.
27. Liu J, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472-9.
28. Prilepskaya V Vitex agnus cactus . Successful treatment of moderate to severe premenstrual syndrome. Maturitas 2006;555:55-63.
29. Sondheimer S. Etiology of premenstrual syndrome. In: Smith S, Schiff I (eds.). Modern management of premenstrual syndrome. New York: Norton Medical Books, 1994:46-53.
30. Wuttke W, et al. Dopaminergic Compounds in Vitex Agnus Castus. In: Loew D, Rietbrock N (Hrsg.). Phytopharmaka in Forschung und kli-nischerAnwendung. Darmstadt: Steinkopff Verlag, 1995:81-91.
31. Lauritzen C, etal. Treatment of premenstrual tension syndrome with Vitex agnus castus: controlled, double-blind study versus pyridoxine. Phytomed 1997;4:183-9.
32. Halaska M. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. Breast 1999;8:175-81.
33. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001;322:134-7.
34. Atmaca M, et al. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol Clin Exp 2003;18:191-5.
35. Kilicdag EB, et al. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. J Gynecol Obstet 2004;85:292-3.
36. Mergner R. Zyklusstörungen. Therapie mit einem Vitex-agnus-castus- haltigenKombinationsarzneimittel. Kassenarzt 1992;7:51-9.
37. Gerhard L, et al. Mastodynon bei weiblicher Sterilität. Forsch Komple-mentärmed 1998;5:272-8.
38. Westphal LM, et al. Double-blind, placebo-controlled study of Fertility-blend: a nutritional supplement for improving fertility in women. Clin Exp Obstet Gynecol 2006;33:205-8.
39. Daniele C, et al. Vitex agnus cactus. A systematic review of adverse events. Drug Saf 2005;28:319-32.